M. Trejeeve (Tre) Martyn, MD
Heart Failure
Highlights
Age Groups Seen
- Adult
Languages
- English
Gender
MaleAbout
Biography
Dr. Martyn is a staff Cardiologist in the section of Heart Failure and Cardiac Transplantation at Cleveland Clinic. He serves as the Director of Heart Failure Population Health for the Cleveland Clinic. In this role, he is focused on scaling efforts to improve heart failure care across a large integrated system. He is a staff physician at Cleveland Clinic Amyloidosis Center.
His research and clinical interests include medical therapy for heart failure, amyloidosis, implementation science, and novel technology in the diagnosis and management of heart failure. He is also actively involved in clinical trials in the areas of heart failure therapeutics, novel devices, and remote monitoring technology. He is a recipient of multiple grants aimed at novel approaches to EHR-based screening for cardiac disease. He has been invited to speak on optimizing heart failure care, regionally, nationally, and internationally. He serves on the older populations committee for the American Heart Association (AHA) and is a member of the Heart Failure Collaboratory (HFC), serving on their digital health committee.
A Phi Beta Kappa graduate of Bowdoin College, he attended Harvard Medical School and completed his internal medicine residency at the University of California San Francisco (UCSF). He completed his general cardiology and Advanced Heart Failure fellowships also at Cleveland Clinic where he served as chief fellow. During his training he completed his Masters in Clinical Research at Case Western Reserve University.
His academic work has been published in JACC, JACC-HF, JACC:CardioOncology, Journal of Cardiac Failure, Circulation Research, and the European Journal of Heart Failure. He was previously editorial board member and digital editor for Circulation and is an ad hoc reviewer for JACC, JACC-HF, Circulation HF, and JCF.
Education & Board Certifications
Education
- Fellowship: Cleveland Clinic, 2022
- Fellowship: Cleveland Clinic, 2021
- Residency: University of California San Francisco Medical Center, 2016
- Medical Education: Harvard Medical School, 2013
Board Certifications
- Advanced Heart Failure and Transplant Cardiology: American Board of Internal Medicine, 2022
- Cardiovascular Disease: American Board of Internal Medicine, 2021
- Internal Medicine: American Board of Internal Medicine, 2016
Innovations & Patents
Research & Publications
See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.
As of 2026-09-04, Dr. Martyn has reported the financial relationships with the companies listed below.
Consulting and/or Speaking. Dr. Martyn receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:
- Novo Nordisk, A/S
- Boehringer Ingelheim
- AstraZeneca
- BridgeBio Pharma, Inc.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.